dr reddy share price update: NYSE $14.38, NSE ₹1,279.90

Introduction: Why dr reddy share price matters

Tracking the dr reddy share price is important for investors, analysts and observers of the pharmaceutical sector. Dr. Reddy’s Laboratories is listed on multiple exchanges, so price movements and analyst targets on different markets can influence portfolio decisions, cross‑market comparisons and sector sentiment. The latest available data shows differing nominal values across the NYSE and NSE listings and a notable analyst price target that implies potential upside.

Main developments and key figures

Analyst outlook

Industry analysts have set a consensus price target of $16.90 for Dr. Reddy’s Laboratories (ticker RDY on the NYSE). That target represents roughly a 17.7% upside from a referenced current price of $14.36. Such consensus targets reflect aggregated analyst estimates but do not guarantee future performance; they provide a benchmark for near‑term expectations.

Market prices and listings

Dr. Reddy’s trades on both US and Indian exchanges. On the NYSE the stock is tracked under the symbol RDY, with a cited current price near $14.36 and a latest closing price of $14.38 as of February 27, 2026. On India’s National Stock Exchange (NSE) the stock appears under the ticker REDY, with a live quoted price of ₹1,279.90. These figures reflect pricing in different currencies and markets; direct comparisons should account for exchange rates and trading session timing.

What the numbers indicate

The gap between the consensus target ($16.90) and the recent NYSE close (~$14.38) is the basis for the ~17.7% upside calculation. Investors monitoring dr reddy share price should note both the analyst sentiment embedded in price targets and the real‑time market quotes on the NSE and NYSE. Cross‑listing means liquidity, currency moves and local demand can affect each listing differently.

Conclusion: Implications for readers

The current data point to modest upside per analyst consensus but also underscore the need to watch both NYSE and NSE prices when evaluating dr reddy share price. If analysts’ consensus materialises, the stock could approach the stated target, but investors should consider currency effects, timing and broader market conditions. Continued monitoring of official market quotes and updated analyst reports is recommended for anyone tracking this stock.